Coherent Inc (COHR)
Operating return on assets (Operating ROA)
| Jun 30, 2025 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Sep 30, 2022 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 535,000 | 123,175 | 50,415 | 81,981 | 116,282 |
| Total assets | US$ in thousands | 487,606,000 | 14,488,600 | 13,711,100 | 13,711,100 | 7,844,850 |
| Operating ROA | 0.11% | 0.85% | 0.37% | 0.60% | 1.48% |
June 30, 2025 calculation
Operating ROA = Operating income ÷ Total assets
= $535,000K ÷ $487,606,000K
= 0.11%
The operating return on assets (ROA) for Coherent Inc. exhibits notable fluctuations over the observed periods, providing insights into the company's operational efficiency in generating income from its assets. As of September 30, 2022, the operating ROA stood at 1.48%, indicating a relatively higher level of efficiency in utilizing assets to generate operating income at that time. However, by June 30, 2023, the ratio declined significantly to 0.60%, reflecting a decrease in operating profitability relative to the company's asset base.
The most recent data, as of September 30, 2023, shows a further decline to 0.37%, suggesting a continuing downward trend in operational efficiency over this period. Conversely, an improvement is observed in the subsequent period ending June 30, 2024, when the operating ROA increased to 0.85%. Despite this rebound, the ratio remains below the levels recorded in 2022, indicating only partial recovery of operational efficiency.
Looking ahead to June 30, 2025, the operating ROA drops sharply to 0.11%, approaching minimal levels of asset profitability from an operating perspective. This decline may signal challenges in asset utilization or reduced profitability margins, potentially attributable to various operational, market, or industry-specific factors affecting the company's performance.
Overall, the trend demonstrates a recent deterioration in Coherent Inc.'s ability to generate operating income from its assets, punctuated by a brief period of recovery. The persistent decline towards very low levels suggests a need for strategic review to address underlying operational efficiency concerns.
Peer comparison
Jun 30, 2025